M. O. Fitzpatrick, H. Muller-Bunz, P. J. Guiry
FULL PAPER
3JC,P = 10 Hz, Ar-CH3), 21.1 (d, 3JC,P = 10 Hz, Ar-CH3), 18.3 (iPr
(S)-4-tert-Butyl-2-{3-[bis(4-fluorophenyl)phosphanyl]thiophen-2-yl}-
CH3), 18.1 (iPr CH3) ppm. 31P NMR (162 MHz, CDCl3): δ = –30.2 4,5-dihydrooxazole (7f): (0.28 g, 33%) was isolated as a sticky white
ppm. IR (KBr disc): ν = 3056, 2960, 1639 cm–1. HRMS calcd.
solid, Rf = 0.25 (pentane/diethyl ether, 9:1). [α]D = –156.7 (c = 0.52,
˜
1
3
for C24H26NOPS (M + 1) 408.1551; found 408.1539. C24H26NOPS
(407.52): calcd. C 70.74, H 6.43, N 3.44; found C 70.44, H 6.40, N
3.41.
CHCl3). H NMR (600 MHz, CDCl3): δ = 7.31 (d, J = 5.0 Hz, 1
H, H5Ј), 7.30–7.22 (m, 4 H, PAr2H’s), 7.04–6.99 (m, 4 H, PAr2H’s),
6.34 (dd, 3J = 5.0, JH,P = 0.8 Hz, 1 H, H4Ј), 4.17 (dd, 3J = 9.9,
3
8.1 Hz, 1 H, H5a), 4.04 (app. t., J = 8.1 Hz, 1 H, H5b), 3.96 (dd, J
3
= 9.9, 8.1 Hz, 1 H, H4), 0.68 (s, 9 H, 3CH3) ppm. 13C NMR
(S)-2-[3-(Di-o-tolylphosphanyl)thiophen-2-yl]-4-phenyl-4,5-dihydro-
oxazole 7d (0.36 g, 38%) was isolated as a white solid, Rf = 0.33
(pentane/diethyl ether); m.p. 70–72 °C. [α]D = –96 (c = 1.04,
1
(150 MHz, CDCl3): δ = 164.2 (d, JC,F = 12 Hz, F-CAr), 162.5 (d,
1JC,F = 12 Hz, F-CAr), 157.9 (d, JC,P = 4 Hz, C1), 141 (d, JC,P
=
3
2
1
3
26 Hz, C2Ј), 135.9–135.7 (m, 2 C, C-o-F), 135.2–134.9 (m, 2 C, C-
o-F), 133.9–133.7 (m, P-CAr), 133.1 (C4Ј), 133.1–133.0 (m, P-CAr),
CHCl3). H NMR (500 MHz, CDCl3): δ = 7.34 (d, J = 5.1 Hz, 1
H, H5Ј), 7.30–7.15 (m, 7 H, Ar H’s), 7.12–7.06 (m, 2 H, Ar H’s),
6.87–6.81 (m, 4 H, Ar H’s), 6.41 (d, 3J = 5.1 Hz, 1 H, H4Ј), 5.33
(dd, 3J = 9.5, 8.3 Hz, 1 H, H4), 4.62 (dd, 3J = 11, 8.3 Hz, 1 H,
1
131.9 (d, JC,P = 22 Hz, C3Ј), 127.7 (C5Ј), 115.8–115.5 (m, 4 C, C-
o-P), 77.0 (C4), 68.9 (C5), 33.8 (CCH3), 25.6 [3 C, (CH3)3] ppm. 31
P
H5a), 3.98 (t, J = 8.3 Hz, 1 H, H5b), 2.47 (d, JC,P = 1.1 Hz, 3 H,
3
3
NMR (162 MHz, CDCl3): δ = –17 (app t, J = 4.3 Hz) ppm. 19F
NMR (376 MHz, CDCl3): δ = –112.8–112.7 (m), –112.3–112.2 (m)
Ar-CH3), 2.39 (d, JC,P = 1.1 Hz, 3 H, Ar-CH3) ppm. 13C NMR
3
(125 MHz, CDCl3): δ = 160 (d, JC,P = 3.6 Hz, C2), 142.7–142.4
3
ppm. IR (KBr disc): ν = 2957, 2917, 2349 cm–1. HRMS calcd. for
˜
(m, 2 C, ArC-CH3), 142.2 (Ph C), 141.3 (d, JC,P = 27 Hz, C2Ј),
2
C23H22F2NOPS (M
+
1) 430.1206, found 430.1219.
136.1–135.5 (m, 2 C, P-CoTol), 133.7 (2 C, C-p-P), 132.8 (d, 2JC,P
=
C23H22F2NOPS (429.47): calcd. C 64.32, H 5.16, N 3.26; found C
64.14, H 5.17, N 3.16.
17 Hz, C4Ј), 131.5 (d, JC,P = 23 Hz, C3Ј), 130.1–130.0 (m, 2 C, C-
1
3
m-P), 128.7 (m, 2 C, C-o-P), 128.4 (m, 2 C, C-m-P), 128.2 (d, JC,P
General Procedure for Asymmetric Heck Reactions: A solution of
Pd2(dba)3 (2.3 mg, 0.002 mmol) and ligand (0.008 mmol) in toluene
(0.5 mL) was stirred at room temperature under nitrogen until it
was evident by the appearance of a transparent solution that the
complex had formed (ca. 1 h). A solution of the required triflate
16, 19 or 22 (0.13 mmol) and tri-n-decane (13 µL, 0.11 mmol) in
toluene (0.5 mL) was added. This was followed by the addition
of 15 (50 µL, 0.65 mmol) and the relevant base (0.78 mmol). The
reaction vessel was sealed and heated to 80 °C for 7 d with precipi-
tation of Base.HOTF proving the reaction was proceeding. The re-
action was cooled to room temperature and pentane (10 mL) was
added. The resulting suspension was filtered through 2 cm of silica
with further elution using diethyl ether (10 mL). This solution was
the concentrated and the yield calculated using GC (Se-30, 11 psi,
50 °C, 4 min, 15 °C/min, 170 °C, 10 min) by the internal standard
method. The determination of the ee values was carried out as
described above. Absolute configuration was assigned by compari-
son with literature values.[2,14]
= 2 Hz, C5Ј), 127.1 (Ph C), 126.4 (2 C, Ph C), 126.1 (2 C, Ph C),
74.9 (C4), 70.2 (C5), 21.3 (d, 2JC,P = 23 Hz, Ar-CH3), 21.2 (d, 2JC,P
= 23 Hz, Ar-CH3) ppm. 31P NMR (121 MHz, CDCl3): δ = –30.4
ppm. IR (KBr disc): ν = 3057, 2850, 1637 cm–1. HRMS calcd.
˜
for C27H24NOPS (M + 1) 442.1394; found 442.1396. C27H24NOPS
(441.53) calcd. C 73.45, H 5.48, N 3.17; found C 73.10, H 5.51, N
3.13.
General Procedure for the Preparation of Di-p-fluorophenylphos-
phane-Derived Ligands 7e–f: Thiophene-2-oxazoline 8 (2 mmol)
was dissolved in diethyl ether (5 mL) and the solution was cooled
to –78 °C. A solution of 2.5 n-butyllithium in hexanes (1.6 mL,
4 mmol) was added dropwise. After addition the reaction was kept
at –78 °C for a further 30 min, then warmed to 0 °C and stirred at
this temperature for 30 min. The reaction was then recooled to
–78 °C and chloro-di-p-fluorophenylphosphane (0.88 mL, 4 mmol)
was carefully added. The reaction was warmed to room tempera-
ture and stirred overnight. It was then quenched with water (5 mL).
The phases were separated and the aqueous phase was extracted
with diethyl ether (2ϫ5 mL). The organic layers were combined,
dried with sodium sulfate and concentrated in vacuo. Purification
was performed using column chromatography on silica gel with
pentane/diethyl ether, 9:1 as the eluent.
Preparation of the Palladium Dichloride Complex 16 of Ligand 7a:
Ligand 7a (6.6 mg, 0.016 mmol) and bis(acetonitrile)dichloropalla-
dium(II) (3.76 mg, 0.015 mmol) were stirred in CH2Cl2 (1 mL) in
a Schlenk tube for 1 h at room temperature. Diethyl ether (1 mL)
was than added slowly down the side of the Schlenk tube and two
layers were formed. The mixture was then left for crystals to form.
The palladium dichloride complex 16 (7.6 mg, 85%) was isolated
as a yellow solid. [α]D = +202 (c = 0.2, CHCl3). 1H NMR
(S)-2-{3-[Bis(4-fluorophenyl)phosphanyl]thiophen-2-yl}-4-isopropyl-
4,5-dihydrooxazole (7e): (0.31 g, 37%) was isolated as a sticky oil.
RF = 0.28 (pentane/diethyl ether, 9:1). [α]D = –118.8 (c = 2.0,
CHCl3). 1H NMR (400 MHz, CDCl3): δ = 7.34–7.22 (m, 5 H, 4
3
(500 MHz, CDCl3): δ = 7.70 (d, J = 4.9 Hz, 1 H, H5Ј), 7.53–7.44
3
(m, 3 H, PAr2H’s), 7.33 (app dd., J = 6.6, 6.3 Hz, 1 H, PAr2 CH),
3
7.15–7.05 (m, 2 H, PAr2H’s), 6.86 (ddd, 3J = 14.0, 7.8, JH,P
=
3
PAr2H’s, H5Ј), 7.05–6.98 (m, 4 H, PAr2 CH’s), 6.35 (dd, J = 5.1,
0.8 Hz, 1 H, PAr2H), 6.60 (app dd., 3J = 3.9, 3.4 Hz, 1 H, H4Ј),
6.36–6.28 (m, 1 H, Ar H), 5.42 (dd, 3J = 8.9, 4.3 Hz, 1 H, H5a),
4.57–4.59 (m, 2 H, H4,5b), 3.05 (s, 3 H, Ar-CH3), 2.76 (s, 3 H, Ar-
CH3), 0.71 [s, 9 H, (CCH3)3] ppm. 13C NMR (125 MHz, CDCl3):
δ = 159.2 (C2), 145.2 (Ar-C-CH3), 143.4 (Ar-C-CH3), 134.2 (C5Ј),
133.8 (C2Ј), 133.0–132.1 (7 C, C2Ј, C4Ј, C5Ј, 4ϫ PAr2 C), 131.5 (PAr2
C), 126.5 (PAr2 C), 125.9 (PAr2 C), 122.6–122.0 (2 C, 2ϫ C-i-P),
73.4 (C4), 72.0 (C5), 34.4 [C(CH3)3], 25.5 [(CH3)3], 24.4 (Ar-CH3),
24.2 (Ar-CH3) ppm. 31P NMR (162 MHz, CDCl3): δ = 3.9 ppm.
IR (KBr disc): δ = 2912, 1701, 1622 cm–1. ESI-HRMS calcd. for
C25H28Cl2NOPPdS (M + 1 – HCl) 562.0353; found 562.0369.
3JH,P = 1.0 Hz, 1 H, H4Ј), 4.23 (dd, 3J = 9.1, 7.7 Hz, 1 H, H5a),
4.02–3.90 (m, 2 H, H4,5b), 1.61–1.54 [m, 1 H, CH(CH3)2], 0.74 (d,
3
3J = 6.7 Hz, 3 H, CH3), 0.70 (d, J = 6.7 Hz, 3 H, CH3) ppm. 13C
NMR (100 MHz, CDCl3: δ = 164.5 (d, 1JC,F = 12 Hz, F-CAr), 162.0
1
3
(d, JC,F = 12 Hz, F-CAr), 155.6 (d, JC,P = 4 Hz, C2), 141.0 (d,
2JC,P = 26 Hz, C2Ј), 135.9–135.5 (m, 2 C, C-o-F), 135.3–134.9 (m,
2 C, C-o-F), 133.7–133.5 (m, P-CAr), 133.0 (C4Ј), 133.0–132.8 (m,
P-CAr), 131.9 (d, JC,P = 22 Hz, C3Ј), 127.8 (C5Ј), 115.8–115.4 (m,
1
4 C, C-o-P), 73.2 (C4), 70.5 (C5), 32.8 [CH(CH3)2], 18.4 (iPr CH3),
18.1 (iPr CH3). 31P NMR (162 MHz, CDCl3): δ = –17 (app. t, J =
4.3 Hz) ppm. 19F NMR (376 MHz, CDCl3) δ = –112.8–112.7 (m),
–112.3–112.2 (m) ppm. IR (KBr disc): ν = 2960, 2873, 2349 cm–1.
Supporting Information (see footnote on the first page of this arti-
cle): Relevant 1H, 13C, 31P and 19F NMR spectra and GC and
HPLC traces are included.
˜
HRMS calcd. for C22H20F2NOPS (M + 1) 416.1050; found
416.1056.
1894
www.eurjoc.org
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2009, 1889–1895